Gemigliptin L-tartrate Sesquihydrate/Metformin Hydrochloride

ๅ‰ๆ ผๅˆ—ๆฑ€้…’็Ÿณ้…ธ็›/็›้…ธไบŒ็”ฒๅŒ่ƒ

Report date: 2022/01/14 13:23:58

Base Information

Drug NameGemigliptin L-tartrate Sesquihydrate/Metformin Hydrochloride
Drug Alias Name็›้…ธไบŒ็”ฒๅŒ่ƒ/ๅ‰ๆ ผๅˆ—ๆฑ€้…’็Ÿณ้…ธ็›gemigliptin and metformin hydrochloridegemigliptin/metformin HClMetformin/gemigliptinGemigliptin/Metformin +[6]ย 
ClassificationSmall molecules
Mechanisms of ActionProtein kinase AMP-activated non-catalytic subunit beta 1 activatorsDipeptidyl peptidase IV inhibitors
TargetsDipeptidyl peptidase IVProtein kinase AMP-activated non-catalytic subunit beta 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2015/01/01
Country/TerritorySouth Korea
CombinationsYes Metformin HydrochlorideGemigliptin L-tartrate Sesquihydrate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLg Chemical Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLg Chemical Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeA10BD18
Related LinksN/A